$BCRX
BIOCRYST PHARMACEUTICALS INC

2020 Q1 Form 10-K Financial Statement

#000117184320001710 Filed on March 13, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 2018 Q4
Revenue $4.823M $48.84M $2.729M
YoY Change -18.07% 136.45% -29.85%
Cost Of Revenue $0.00 $3.726M $70.00K
YoY Change -100.0% -46.15%
Gross Profit $4.823M $45.11M $2.660M
YoY Change 7.46% 118.41% -29.26%
Gross Profit Margin 100.0% 92.37% 97.47%
Selling, General & Admin $15.87M $37.12M $4.190M
YoY Change 154.33% 25.77% -10.85%
% of Gross Profit 328.94% 82.29% 157.52%
Research & Development $29.87M $107.1M $23.43M
YoY Change 8.63% 26.13% 38.48%
% of Gross Profit 619.26% 237.35% 880.83%
Depreciation & Amortization $218.0K $724.0K $200.0K
YoY Change 23.86% -5.97% 11.11%
% of Gross Profit 4.52% 1.61% 7.52%
Operating Expenses $45.73M $144.2M $27.62M
YoY Change 35.58% 26.04% 27.75%
Operating Profit -$40.98M -$99.46M -$24.96M
YoY Change 39.71% 5.56% 39.75%
Interest Expense $3.047M $11.89M -$2.170M
YoY Change 11.78% 29.6% 29.17%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$37.60M -$108.9M -$27.43M
YoY Change 21.1% 7.55% 40.38%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$37.60M -$108.9M -$27.43M
YoY Change 21.08% 7.55% 40.37%
Net Earnings / Revenue -779.58% -222.99% -1005.2%
Basic Earnings Per Share
Diluted Earnings Per Share -$243.9K -$942.0K -$249.6K
COMMON SHARES
Basic Shares Outstanding 154.2M
Diluted Shares Outstanding 154.2M 115.6M

Balance Sheet

Concept 2020 Q1 2019 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $113.1M $136.2M $104.5M
YoY Change 5.11% 30.33% -8.68%
Cash & Equivalents $101.9M $114.2M $26.73M
Short-Term Investments $11.19M $22.10M $77.74M
Other Short-Term Assets $6.800M $6.000M $4.000M
YoY Change 51.11% 50.0% -18.37%
Inventory $0.00 $1.649M
Prepaid Expenses
Receivables $5.642M $22.10M $4.293M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $125.5M $164.3M $114.4M
YoY Change 6.68% 43.62% -8.8%
LONG-TERM ASSETS
Property, Plant & Equipment $7.270M $10.90M $9.135M
YoY Change -4.89% 19.78% -4.31%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $22.40M
YoY Change -100.0% -45.76%
Other Assets $3.811M $978.0K
YoY Change -29.29% -51.75%
Total Long-Term Assets $11.08M $11.00M $32.49M
YoY Change -55.12% -66.05% -38.55%
TOTAL ASSETS
Total Short-Term Assets $125.5M $164.3M $114.4M
Total Long-Term Assets $11.08M $11.00M $32.49M
Total Assets $136.6M $175.3M $146.8M
YoY Change -4.04% 19.41% -17.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.06M $14.00M $7.769M
YoY Change 45.08% 79.49% 22.6%
Accrued Expenses $20.19M $37.60M $15.89M
YoY Change 22.03% 35.74% 25.14%
Deferred Revenue
YoY Change
Short-Term Debt $29.70M $29.60M $29.10M
YoY Change 1.71% 1.72% 1.39%
Long-Term Debt Due $14.00M $9.000M $4.600M
YoY Change 95.65% -29.23%
Total Short-Term Liabilities $92.70M $92.30M $69.48M
YoY Change 39.76% 32.81% -7.16%
LONG-TERM LIABILITIES
Long-Term Debt $36.50M $41.30M $28.10M
YoY Change -26.41% 46.98% 44.1%
Other Long-Term Liabilities $3.700M $3.400M $2.703M
YoY Change -4.86% 3300.0% 1251.5%
Total Long-Term Liabilities $40.20M $44.70M $2.703M
YoY Change 933.68% 58.51% -86.28%
TOTAL LIABILITIES
Total Short-Term Liabilities $92.70M $92.30M $69.48M
Total Long-Term Liabilities $40.20M $44.70M $2.703M
Total Liabilities $132.9M $137.0M $72.18M
YoY Change 89.28% 40.37% -23.62%
SHAREHOLDERS EQUITY
Retained Earnings -$878.2M -$732.0M
YoY Change 15.13% 15.85%
Common Stock $1.542M $1.101M
YoY Change 39.8% 11.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.648M $38.30M $49.24M
YoY Change
Total Liabilities & Shareholders Equity $136.6M $175.3M $146.8M
YoY Change -4.04% 19.41% -17.62%

Cashflow Statement

Concept 2020 Q1 2019 2018 Q4
OPERATING ACTIVITIES
Net Income -$37.60M -$108.9M -$27.43M
YoY Change 21.08% 7.55% 40.37%
Depreciation, Depletion And Amortization $218.0K $724.0K $200.0K
YoY Change 23.86% -5.97% 11.11%
Cash From Operating Activities -$23.28M -$89.58M -$23.99M
YoY Change -13.77% -3.22% 128.04%
INVESTING ACTIVITIES
Capital Expenditures -$120.0K $343.0K -$110.0K
YoY Change 33.33% -6.28% -8.33%
Acquisitions
YoY Change
Other Investing Activities $10.84M $78.28M -$3.070M
YoY Change -32.12% 1425.93% -94.49%
Cash From Investing Activities $10.72M $77.93M -$3.170M
YoY Change -32.47% 1534.52% -94.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $58.50M
YoY Change 9.55%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $266.0K $99.10M 1.330M
YoY Change -98.67% 58.55% 133.33%
NET CHANGE
Cash From Operating Activities -$23.28M -$89.58M -23.99M
Cash From Investing Activities $10.72M $77.93M -3.170M
Cash From Financing Activities $266.0K $99.10M 1.330M
Net Change In Cash -$12.29M $87.45M -25.83M
YoY Change -237.75% -445.74% -60.72%
FREE CASH FLOW
Cash From Operating Activities -$23.28M -$89.58M -$23.99M
Capital Expenditures -$120.0K $343.0K -$110.0K
Free Cash Flow -$23.16M -$89.93M -$23.88M
YoY Change -13.93% -3.23% 129.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 bcrx Accrued Development Costs
AccruedDevelopmentCosts
11302000
CY2018Q4 bcrx Accrued Development Costs
AccruedDevelopmentCosts
7564000
CY2019Q4 bcrx Accrued Inventory Expense
AccruedInventoryExpense
29000
CY2018Q4 bcrx Accrued Inventory Expense
AccruedInventoryExpense
1649000
CY2019 bcrx Amortization Of Discount And Premium On Investments
AmortizationOfDiscountAndPremiumOnInvestments
117000
CY2018 bcrx Amortization Of Discount And Premium On Investments
AmortizationOfDiscountAndPremiumOnInvestments
110000
CY2017 bcrx Amortization Of Discount And Premium On Investments
AmortizationOfDiscountAndPremiumOnInvestments
157000
CY2019Q4 bcrx Available For Sale Debt Securities Accrued Interest
AvailableForSaleDebtSecuritiesAccruedInterest
116000
CY2018Q4 bcrx Available For Sale Debt Securities Accrued Interest
AvailableForSaleDebtSecuritiesAccruedInterest
444000
CY2019Q4 bcrx Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
CY2018Q4 bcrx Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
22376000
CY2019 bcrx Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
11765000
CY2019Q4 bcrx Deferred Tax Assets Leasing Obligations
DeferredTaxAssetsLeasingObligations
1070000
CY2018Q4 bcrx Deferred Tax Assets Leasing Obligations
DeferredTaxAssetsLeasingObligations
CY2019Q4 bcrx Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
803000
CY2018Q4 bcrx Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
CY2019 bcrx Effective Income Tax Rate Reconciliation Tax Credit Orphan Drug Amount
EffectiveIncomeTaxRateReconciliationTaxCreditOrphanDrugAmount
CY2018 bcrx Effective Income Tax Rate Reconciliation Tax Credit Orphan Drug Amount
EffectiveIncomeTaxRateReconciliationTaxCreditOrphanDrugAmount
CY2017 bcrx Effective Income Tax Rate Reconciliation Tax Credit Orphan Drug Amount
EffectiveIncomeTaxRateReconciliationTaxCreditOrphanDrugAmount
564000
CY2019Q4 bcrx Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year Four
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedYearFour
2113000
CY2019Q4 bcrx Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year Three
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedYearThree
6743000
CY2019Q4 bcrx Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year Two
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedYearTwo
7950000
CY2019Q4 bcrx Employee Service Sharebased Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Next Year
EmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedNextYear
9746000
CY2019 bcrx Income Tax Rate Reconciliation Adoption Of Accounting Standards Update Amount
IncomeTaxRateReconciliationAdoptionOfAccountingStandardsUpdateAmount
CY2018 bcrx Income Tax Rate Reconciliation Adoption Of Accounting Standards Update Amount
IncomeTaxRateReconciliationAdoptionOfAccountingStandardsUpdateAmount
CY2017 bcrx Income Tax Rate Reconciliation Adoption Of Accounting Standards Update Amount
IncomeTaxRateReconciliationAdoptionOfAccountingStandardsUpdateAmount
5949000
CY2019 bcrx Income Tax Reconciliation Income Tax Expense Benefit Expiration Of Carry Forwards
IncomeTaxReconciliationIncomeTaxExpenseBenefitExpirationOfCarryForwards
3976000
CY2018 bcrx Income Tax Reconciliation Income Tax Expense Benefit Expiration Of Carry Forwards
IncomeTaxReconciliationIncomeTaxExpenseBenefitExpirationOfCarryForwards
2183000
CY2017 bcrx Income Tax Reconciliation Income Tax Expense Benefit Expiration Of Carry Forwards
IncomeTaxReconciliationIncomeTaxExpenseBenefitExpirationOfCarryForwards
918000
CY2019 bcrx Increase Decrease In Financing Lease Obligations
IncreaseDecreaseInFinancingLeaseObligations
CY2018 bcrx Increase Decrease In Financing Lease Obligations
IncreaseDecreaseInFinancingLeaseObligations
-76000
CY2017 bcrx Increase Decrease In Financing Lease Obligations
IncreaseDecreaseInFinancingLeaseObligations
122000
CY2017Q4 bcrx Maximum Aggregate Offering Price
MaximumAggregateOfferingPrice
200000000
CY2019Q4 bcrx Operating Lease Rightofuse Asset Accumulated Amortization
OperatingLeaseRightofuseAssetAccumulatedAmortization
1386
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Type
DocumentType
10-K
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0000882796
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
154191951
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019Q2 dei Entity Public Float
EntityPublicFloat
413929804
CY2019 dei Entity Registrant Name
EntityRegistrantName
BIOCRYST PHARMACEUTICALS INC
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019 dei Entity Small Business
EntitySmallBusiness
false
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2019 dei Security12b Title
Security12bTitle
Common Stock, $.01 Par Value
CY2019 dei Trading Symbol
TradingSymbol
bcrx
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
13988000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7769000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22146000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4293000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
21365000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15891000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
326000
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
118000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6588000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6095000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
39000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-297000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
877300000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
780400000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12621000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9396000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17719000
CY2019 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
19882000
CY2019 us-gaap Advertising Expense
AdvertisingExpense
0
CY2018 us-gaap Advertising Expense
AdvertisingExpense
0
CY2017 us-gaap Advertising Expense
AdvertisingExpense
0
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17719000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9396000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12621000
CY2019 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1278000
CY2018 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
885000
CY2017 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
876000
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2805000
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2274000
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2067000
CY2019Q4 us-gaap Assets
Assets
175282000
CY2018Q4 us-gaap Assets
Assets
146841000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
164345000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
114352000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
40000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
19000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
316000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
21899000
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
99965000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
22054000
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
77736000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
22376000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
22054000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
100112000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
22054000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
77736000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
114172000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26731000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
28275000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
53568000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
23650000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
115723000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
87448000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-25293000
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
29918000
CY2019Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.01
CY2019Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
11765000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
154082000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
110063000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
154082000
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
110063000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
1541000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
1101000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
209109000
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-101306000
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-66013000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
233122000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-108561000
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3726000
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
CY2017 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1142000
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
148290000
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
114873000
CY2017 us-gaap Costs And Expenses
CostsAndExpenses
82597000
CY2017Q4 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
1126000
CY2018Q4 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
238000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
917000
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
649000
CY2019Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
54000
CY2019Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2120000
CY2018Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
221000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
155190000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
137234000
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3801000
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
5258000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
63275000
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
59509000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
9786000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
7108000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
232205000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
208460000
CY2019Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
114000
CY2018Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
418000
CY2019Q4 us-gaap Deferred Tax Liabilities Unrealized Currency Transaction Gains
DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains
CY2018Q4 us-gaap Deferred Tax Liabilities Unrealized Currency Transaction Gains
DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains
231000
CY2019 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
926000
CY2018 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
724000
CY2017 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
664000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
724000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
770000
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
704000
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.94
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.98
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.78
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.25
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6190000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4659000
CY2019Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
26552000
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1377000
CY2018Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
47000
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
3406000
CY2018Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
2703000
CY2019 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
CY2018 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-7000
CY2017 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
12000
CY2019 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
517000
CY2018 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-108000
CY2017 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-821000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017Q4 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
73474000
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
23824000
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
26040000
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-42625000
CY2019 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
625000
CY2018 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-29000
CY2017 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
71155000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-22868000
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-21263000
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-23024000
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
691000
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
503000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
910000
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
281000
CY2018 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
18000
CY2017 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1639000
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1591000
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-2547000
CY2017 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1611000
CY2019 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
4938000
CY2018 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
4905000
CY2017 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1977000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
11741000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4487000
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3842000
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1899000
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-7079000
CY2017 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1722000
CY2019 us-gaap Increase Decrease In Derivative Assets
IncreaseDecreaseInDerivativeAssets
-347000
CY2018 us-gaap Increase Decrease In Derivative Assets
IncreaseDecreaseInDerivativeAssets
-1049000
CY2017 us-gaap Increase Decrease In Derivative Assets
IncreaseDecreaseInDerivativeAssets
-966000
CY2019 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
3056000
CY2018 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-247000
CY2017 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
3105000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1649000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1649000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-500000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1364000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
866000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-951000
CY2019 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
17853000
CY2018 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-1824000
CY2017 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-2651000
CY2018 us-gaap Interest Expense Debt
InterestExpenseDebt
9176000
CY2017 us-gaap Interest Expense Debt
InterestExpenseDebt
8565000
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
14904000
CY2018Q4 us-gaap Interest Payable Current
InterestPayableCurrent
11848000
CY2019Q4 us-gaap Inventory Net
InventoryNet
CY2018Q4 us-gaap Inventory Net
InventoryNet
1649000
CY2019 us-gaap Interest And Other Income
InterestAndOtherIncome
1933000
CY2018 us-gaap Interest And Other Income
InterestAndOtherIncome
2252000
CY2017 us-gaap Interest And Other Income
InterestAndOtherIncome
1015000
CY2019 us-gaap Interest Expense
InterestExpense
11892000
CY2018 us-gaap Interest Expense
InterestExpense
9176000
CY2017 us-gaap Interest Expense
InterestExpense
8565000
CY2019 us-gaap Interest Expense Debt
InterestExpenseDebt
11892000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
10873000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
7249000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1465000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
518000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
515000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
531000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
595000
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6090000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
175282000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
146841000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
92335000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
69477000
CY2019Q4 us-gaap Line Of Credit
LineOfCredit
41289000
CY2018Q4 us-gaap Line Of Credit
LineOfCredit
25372000
CY2019Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
9020000
CY2018Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
4580000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
50000000
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
10000000
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
20000000
CY2019Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
20000000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
99098000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
62504000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
135703000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
77934000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4768000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-64642000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-89584000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-92565000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-41143000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-65782000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-101252000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-108897000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-31054000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-37629000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-37592000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-2622000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-25777000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-18446000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-29597000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-27432000
CY2019Q4 us-gaap Notes Payable Current
NotesPayableCurrent
29561000
CY2018Q4 us-gaap Notes Payable Current
NotesPayableCurrent
29121000
CY2019 us-gaap Open Tax Year
OpenTaxYear
2016 2017 2018 2019
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-99455000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-94220000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-57411000
CY2019 us-gaap Operating Lease Expense
OperatingLeaseExpense
1464000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
1457000
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.127
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P13Y109D
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3451000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1850000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3590000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
978000
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-231000
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-54000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
336000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
336000
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-54000
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-231000
CY2019 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
3018000
CY2018 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
62614000
CY2017 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
107787000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
343000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
366000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
328000
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4422000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2399000
CY2018Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
53400000
CY2019Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
53500000
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
58500000
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
53400000
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
134000000
CY2019Q4 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
19882000
CY2019 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
19882000
CY2018 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
CY2017 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
CY2019 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
19477000
CY2018 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
10353000
CY2017 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
CY2019 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
81295000
CY2018 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
67748000
CY2017 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
43461000
CY2019 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
CY2018 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
CY2017 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
12000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1239000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2852000
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1581000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13935000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15230000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7347000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9135000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
107068000
CY2018 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
4025000
CY2017 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
CY2019Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
22146000
CY2018Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
4293000
CY2019 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
0
CY2018 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
2000
CY2019 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
84888000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
66962000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1551000
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1544000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-840628000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-731969000
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
48835000
CY2018 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
20653000
CY2017 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
25186000
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5887000
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1448000
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1775000
CY2019Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
39725000
CY2018Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3976000
CY2018Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
12494000
CY2018Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1454000
CY2018Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2729000
CY2019 us-gaap Royalty Expense
RoyaltyExpense
375000
CY2018 us-gaap Royalty Expense
RoyaltyExpense
471000
CY2017 us-gaap Royalty Expense
RoyaltyExpense
560000
CY2018Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10455000
CY2019Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
43621000
CY2017 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
345000
CY2018 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
351000
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
37121000
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
29514000
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13933000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
17719000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
9396000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
12621000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
704000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
5891000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.58
CY2019 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
404000
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
134000000
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
53400000
CY2019Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.69
CY2019 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
0
CY2019Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
10691000
CY2019Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
22379000
CY2019 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
18
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
9295000
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
11688000
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
4.38
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
4.78
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
3.77
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
2794000
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
4.48
CY2019Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
6.31
CY2019Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
5.82
CY2019 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P6Y328D
CY2018Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
5.50
CY2019Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.45
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
58500000
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1236000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2501000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
835000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
1578000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
83767000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
49235000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
38252000
CY2019Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
67000
CY2018Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
51000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5976000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4750000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
7210000
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
CY2018 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
CY2018Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2017Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2019Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1234000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1226000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0 0pt 12.1pt"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0 0pt 12.1pt">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 29.7pt; margin: 0pt 0">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. The most significant estimates in the Company&#x2019;s consolidated financial statements relate to the valuation of stock options, and the valuation allowance for deferred tax assets resulting from net operating losses. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> readily apparent from other sources. Actual results could differ from those estimates.&nbsp;&nbsp;</div></div></div></div></div></div></div></div></div></div>
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115600000
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
103185000
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84451000

Files In Submission

Name View Source Status
0001171843-20-001710-index-headers.html Edgar Link pending
0001171843-20-001710-index.html Edgar Link pending
0001171843-20-001710.txt Edgar Link pending
0001171843-20-001710-xbrl.zip Edgar Link pending
bcrx-20191231.xml Edgar Link completed
bcrx-20191231.xsd Edgar Link pending
bcrx-20191231_cal.xml Edgar Link unprocessable
bcrx-20191231_def.xml Edgar Link unprocessable
bcrx-20191231_lab.xml Edgar Link unprocessable
bcrx-20191231_pre.xml Edgar Link unprocessable
exh_1018.htm Edgar Link pending
exh_1083.htm Edgar Link pending
exh_21.htm Edgar Link pending
exh_23.htm Edgar Link pending
exh_311.htm Edgar Link pending
exh_321.htm Edgar Link pending
exh_41.htm Edgar Link pending
f10k_031320p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
graph1.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending